Dataset summary
TF Name: | MYCN | Species: | Mus musculus |
Cell-type/Tissue: | neuroblastoma (Th-MYCN) | Condition/Source: | None |
JASPAR ID: | MA0104.4 | Collections: | Permissive Robust |
References: | GEO GSE100538 GSM2686165 GTRD EXP040348 PUBMED 29379199 |
Statistical details
Model | Peak caller | Model ID | Enrichment Zone | TFBSs | Score threshold | Centrality p-value (log10) |
---|---|---|---|---|---|---|
DAMO | MACS | MA0104.4 | 0.5 | 4 | 87.5 | -3.13894740579239 |
32 datasets found for the same TF (MYCN) in other cell-types/tissues
TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
---|---|---|---|---|---|---|
MYCN | Tet21N (neuroblastoma) | None | Permissive Robust | Homo sapiens | GSE80150 ... | MA0104.4 |
MYCN | Tet21N (neuroblastoma) | 0.2 ug/mL DOX for 24HR | Permissive | Homo sapiens | GSE80150 ... | MA0104.4 |
MYCN | Tet21N (neuroblastoma) | 0.2 ug/mL DOX for 2HR | Permissive Robust | Homo sapiens | GSE80150 ... | MA0104.4 |
MYCN | neuroblastoma (Th-MYCN) | None | Permissive Robust | Mus musculus | GSE100538 ... | MA0104.4 |
MYCN | neuroblastoma (Th-MYCN) | None | Permissive Robust | Mus musculus | GSE100538 ... | MA0104.4 |
MYCN | IMR-5 (Neuroblastoma) | Treatment: DMSO for 4 hr | Permissive Robust | Homo sapiens | GSE78957 ... | MA0104.4 |
MYCN | IMR-5 (Neuroblastoma) | Treatment: 1uM CD532 for 4 hr | Permissive Robust | Homo sapiens | GSE78957 ... | MA0104.4 |
MYCN | HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells | mTreatment: mycn-low lvl induced by 16 hr doxycycline | Permissive Robust | Homo sapiens | GSE83317 ... | MA0104.4 |
MYCN | MYCN3 (neuroblastoma cell line with inducible MYCN expression) | Treatment: mycn-high lvl induced by 16 hr doxycycline | Permissive Robust | Homo sapiens | GSE83317 ... | MA0104.4 |
MYCN | BE2C | Treatment: untreated | Permissive Robust | Homo sapiens | GSE94822 ... | MA0104.4 |
MYCN | Kelly (neuroblastoma) | Treatment: untreated | Permissive Robust | Homo sapiens | GSE94822 ... | MA0104.4 |
MYCN | SH-EP-NMYCER | Treatment: 200 nM EtOH continuously for 3 hrs; | Permissive | Homo sapiens | GSE111905 ... | MA0104.4 |
MYCN | SH-EP-NMYCER | Treatment: 200 nM 4-OHT continuously for 3 hrs; | Permissive Robust | Homo sapiens | GSE111905 ... | MA0104.4 |
MYCN | embryonic stem cells | Permissive Robust | Mus musculus | GSE11431 ... | MA0104.4 | |
MYCN | medulloblastoma, type G3 | Permissive | Mus musculus | GSE64425 ... | MA0104.4 | |
MYCN | Sonic Hedgehog medulloblastoma | Permissive Robust | Mus musculus | GSE64425 ... | MA0104.4 | |
MYCN | RH4 (alveolar rhabdomyosarcoma) | Permissive | Homo sapiens | GSE83726 ... | MA0104.4 | |
MYCN | NGP (neuroblastoma) | Permissive Robust | Homo sapiens | GSE94782 ... | MA0104.4 | |
MYCN | Kelly (neuroblastoma) | Permissive Robust | Homo sapiens | GSE94782 ... | MA0104.4 | |
MYCN | NB-1643 (neuroblastoma) | Permissive Robust | Homo sapiens | GSE94782 ... | MA0104.4 | |
MYCN | Permissive | Homo sapiens | ERP013415 | MA0104.4 | ||
MYCN | Permissive | Homo sapiens | ERP013415 | MA0104.4 | ||
MYCN | BE2C | Permissive Robust | Homo sapiens | GSE72640 | MA0104.4 | |
MYCN | BE2C | Permissive Robust | Homo sapiens | GSE80151 | MA0104.4 | |
MYCN | Kelly (neuroblastoma) | Permissive Robust | Homo sapiens | GSE80151 | MA0104.4 | |
MYCN | NGP (neuroblastoma) | Permissive Robust | Homo sapiens | GSE80151 | MA0104.4 | |
MYCN | SH-SY5Y (neuroblastoma) | OVERMYCN_24H | Permissive | Homo sapiens | ERP013415 | MA0104.4 |
MYCN | SH-SY5Y (neuroblastoma) | OVERMYCN_48H | Permissive | Homo sapiens | ERP013415 | MA0104.4 |
MYCN | DOX_0H | Permissive Robust | Homo sapiens | GSE80151 | MA0104.4 | |
MYCN | DOX_24H | Permissive | Homo sapiens | GSE80151 | MA0104.4 | |
MYCN | SH-SY5Y (neuroblastoma) | Permissive | Homo sapiens | ERP013415 | MA0104.4 | |
MYCN | Permissive Robust | Homo sapiens | GSE80151 | MA0104.4 |